Close X
Attorney Spotlight

What colorful method does Claire Miley use to keep up with the latest healthcare regulations as they relate to proposed transactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Securities Law Exchange BlogSecurities Law Exchange blog offers insight on the latest legal and regulatory developments affecting publicly traded companies. It focuses on a wide variety of topics including regulation and reporting updates, public company advisory topics, IPO readiness and exchange updates including IPO announcements, M&A trends and deal news.

Read More >

Mark Manner

Member

Nashville
(615) 742-6298 TEL
(615) 742-2897 FAX

Mark Manner

Member

Nashville
(615) 742-6298 TEL
(615) 742-2897 FAX
Nashville
(615) 742-6298 TEL
(615) 742-2897 FAX

For more than 35 years, Mark Manner has provided counsel to corporate boards, executives and significant shareholders on governance, securities issuances and disclosures, private equity and mergers and acquisitions. He applies his years of experience to effectively navigate complex interpersonal relationships in order to resolve issues and enhance shareholder value. He has substantial experience structuring and negotiating complex mergers, acquisitions, private equity and securities transactions, initial and follow-on securities offerings, venture capital financings and leveraged buyouts.

Mark has earned a national reputation in corporate law and has been recognized by Chambers USA as an "excellent attorney" who "draws upon over 35 years of experience to skillfully handle M&A and private equity transactions, as well as provide in-depth advice on corporate governance matters. They also point out his 'outstanding level of experience' advising on complex healthcare transactions." (from Chambers USA 2016) Working closely with senior management, boards of directors and shareholders, Mark's practice includes:

  • Leadership on corporate governance issues.
  • Guidance on SEC disclosure requirements and filings.
  • Advice related to capital markets issues.
  • Counsel on SEC regulations and compliance.
  • Representation in mergers, acquisitions and other strategic corporate transactions.

Prior to joining Bass, Berry & Sims, Mark was a founding member and served as the managing shareholder at Harwell Howard Hyne Gabbert & Manner, P.C. Previously he worked in Washington, D.C. with the Appellate Section of the Antitrust Division of the U.S. Department of Justice, and served as a Special Assistant U.S. Attorney in Alexandria, Virginia.

Memberships

Nashville Bar Association

Tennessee Bar Association

American Health Lawyers Association (AHLA)

Life Science Tennessee — Founding Member, Board of Directors (former), Of Counsel

Nashville Health Care Council — Board of Directors (former)

Tennessee Technology Development Corporation — Board of Directors (former)

The Land Trust for Tennessee — Chair, Board of Directors

Dyer Observatory of Vanderbilt University — Adviser

Long Mountain Observatory of Montgomery Bell Academy — Adviser

KELT-North – Survey for Transiting Exoplanets — Team Member

News

View More

Representative Experience

View More

Additional Experience

Counselor and Senior Adviser to Control Shareholders, Boards of Directors and Executive Management

Mark has advised significant shareholders, senior executive management and boards of directors of public and private companies on corporate governance, securities and debt issuances, strategic acquisitions, proxy and control contests and high level business strategy and implementation. Companies represented include:

  • Diversicare Healthcare Services, Inc.
  • ALS Education, Inc.
  • American Health Companies, Inc.
  • Aegis Health Group, Inc.
  • Tractor Supply Company
  • The Car Park
  • Central Parking Corporation
  • Utah Medical Products, Inc.
  • National Healthcare Corporation (NHC)
  • National Health Investors, Inc. (NHI)
  • Counsel Corporation
  • Pharmerica, Inc.
  • American HomePatient, Inc.
  • Stadtlander Drug Company
  • BioMimetic Pharmaceuticals, Inc.
  • Clintrials Research, Inc.
  • International Clinical Laboratories, Inc.
  • Advocat, Inc.
  • Wessex Corporation
  • Celeris Corp.

Media Mentions

View More

Accolades

Chambers USA — Corporate/M&A, Healthcare (2005-2016)

Best Lawyers in America® — Nashville Corporate Governance Law "Lawyer of the Year" (2011, 2012, 2014)

Best Lawyers in America® — Corporate Governance Law; Corporate Law; Healthcare Law; Mergers and Acquisitions Law; Securities / Capital Markets Law (1995-2017)

Martindale-Hubbell — AV Preeminent® Peer Review Rated

Nashville Post "In Charge" — Legal Sector (2015-2016)

Mid-South Super Lawyers (2006-2010, 2016)

Top 100 Tennessee Super Lawyers (2007, 2009)

Nashville Business Journal "Best of the Bar" (2003-2005, 2012)

Nashville Post "101 Best Lawyers" (2011)

Nashville Business Journal "Healthcare 100" (2004-2007)

Memphis State University Law Review — Editor-in-chief

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.